Blanket Purchase Agreement V797D70105-36C25021A0051

Award Date 2/5/21
Last Date to Order 2/4/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Roche Diagnostics Corporation, a global manufacturer and distributor of in vitro diagnostics, laboratory equipment, and associated products and services. The BPA, valued at up to $1,852,813.60, is for the provision of reagents and consumables to support human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing at VA medical facilities within the VA's...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The BPA, valued at up to $3,020,685.50, provides the VA's Veterans Integrated Service Network 16 with a streamlined vehicle to acquire HIV, hepatitis B (HBV), and hepatitis C (HCV) testing reagents and supplies on an as-needed basis over a 5-year period ending in October 2024. The...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of CTNG/HPV reagents and supplies to support the Minneapolis VA Medical Center. The BPA has a total potential value of $221,186.26 and consists of two task orders: The first task order is a $150,162.95 BPA call awarded on October 1, 2023, with a period of performance through September 30, 2024. The second task order...
Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, has been awarded a Blanket Purchase Agreement (BPA) by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide in vitro diagnostics, reagents, and test supplies under the General Services Administration (GSA) Federal Supply Schedule 65-VII. The 5-year master BPA, with a ceiling value of $217,396.88, establishes a streamlined ordering mechanism for the VA's Veterans Integrated Service...
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $1,041,901.25, allows the VA network to acquire CPRR microbiology reagents from Roche on an as-needed basis over the contract's term through September...
This Blanket Purchase Agreement (BPA) with Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides the Department of Veterans Affairs (VA) with laboratory instruments, reagents, test kits, and associated products and services. The 5-year BPA, valued at over $7 million, was awarded by the VA's Veterans Integrated Service Network 2 to supply chemistry and immunochemistry laboratory testing capabilities at VA hospitals in the Bronx, New York area. Roche Diagnostics, a...
This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, is for the provision of molecular diagnostic viral testing reagents and supplies. The $452,140.05 BPA call, issued under Roche's General Services Administration (GSA) Critical Analyzers, Laboratory (FSS-66-III) schedule contract, has an ultimate completion date of...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA has a ceiling value of $139,514.30 and a period of performance through November 30, 2029. It was awarded on a sole source basis to provide Roche Coaguchek Strips, Controls, BPA Plus RALS Modules, and Device Charges to the VA's Veterans...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide ROCHE POC/INR testing, RALS software, and accessories. The single-award BPA, valued at over $7 million, has a period of performance through February 28, 2030. This contract establishes a long-term vehicle for the VA to acquire a variety of Roche's in vitro diagnostics, reagents, laboratory instruments, and associated...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The $487,747.35 BPA contract, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), will provide the VA with critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The contract supports the provision of...

The Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The 5-year BPA, valued at $630,030.40, is for the provision of human papillomavirus (HPV) testing equipment, supplies, and preventive maintenance services.

The BPA is set up as a master contract, with individual delivery orders issued annually to acquire the required HPV testing capabilities. To date, the VA has awarded four option year delivery orders totaling over $400,000 under this BPA. The delivery orders provide HPV testing equipment, supplies, and preventive maintenance services to support VA healthcare operations and ensure veterans receive needed medical screening and diagnostic testing services nationwide. Roche Diagnostics has a long history of providing critical care analyzers, reagents, test kits, and other laboratory equipment and supplies to various federal agencies, often through General Services Administration (GSA) schedule contracts.

Generated 1/24/25, 9:05 AM